Stock listing
U.s. Stem Cell, Inc.
Selected listing: USRM · OTC · USD · US
U.s. Stem Cell, Inc. (OTC:USRM), Health Technology. Latest release Sep 1, 2022: Court Reports Favorable Judgment in California Stem Cell Case.
- Ticker
- OTC:USRM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About U.s. Stem Cell, Inc.
U.S. Stem Cell, Inc. is a public company listed under the ticker USRM, operating in the American market. U.S. Stem Cell focuses on advancements in stem cell therapies and regenerative medicine.
Latest news from U.s. Stem Cell, Inc.
Court Reports Favorable Judgment in California Stem Cell Case
August 31, 2022
Mark Borman Appointed Chairman of the Board of USRM
March 8, 2022
USRM to Focus on Animal Health and Lead Pet-Care Innovation
October 17, 2021
Corrected: USRM Posts Earnings for Second Quarter 2019
August 9, 2019
USRM Posts Earnings for Second Quarter 2019
August 7, 2019
Research U.s. Stem Cell, Inc.
U.s. Stem Cell, Inc. company profile
View the public company page for U.s. Stem Cell, Inc. on 6ix.
U.s. Stem Cell, Inc. news
Read company news and market updates connected to U.s. Stem Cell, Inc..
U.s. Stem Cell, Inc. investor events
Find investor webinars, events, and replay context for U.s. Stem Cell, Inc..